Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GV1001 in Inoperable Stage III NSCLC
NCT01579188Phase 3Unknown
- Sponsor
- GemVax & KAEL Co., Ltd.
- Start
- May 2012
- Primary completion
- May 2016
- Modality
- Peptides, Vaccines & Immunotherapeutics
01
Overview
A Phase 3 trial of tertomotide in non-small cell lung cancer (NSCLC), sponsored by GemVax & KAEL Co., Ltd.. Status: unknown.
02
Drugs
tertomotide
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT01579188.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01579188.